Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1574.6000 13.80 (0.88%)
NSE Sep 12, 2025 15:51 PM
Volume: 785.5K
 

logo
Cipla Ltd.
28 May 2019
1574.60
0.88%
Way2Wealth
Cipla reported a strong set of numbers with revenue/EBITDA/PAT growth of 19%/75%/54% (adjusted for an exceptional item in Q4FY18). Revenue growth during the quarter was driven by India (11%), North America (53%), and Europe (73%) business. For FY19, revenue grew by 9% aided by India (7%) and North America (29%) markets while African tendering arm remained under pressure. EBITDA grew by 75% YoY to `972 Cr during the quarter. EBITDA margins for the quarter stood at 22%, expansion of ~700bps YoY. Net profit was reported at `358 Cr for the quarter....
Cipla Ltd. has an average target of 1702.60 from 10 brokers.
More from Cipla Ltd.
Recommended